Remove Academics Remove Evidence-Based Practice Remove Shock
article thumbnail

PROFID EHRA: The Most Important Trial of the Decade in Cardiology

Sensible Medicine

Yet, still, the vast majority (≈13 of 14) of patients implanted with an ICD for primary prevention never receive a shock, and therefore gain no benefit. Keep in mind that the ICD is a dumb device—as it saves lives by shocking a malignant arrhythmia back to normal. Plus, it’s in mortality, not a composite endpoint.